Call for Abstracts of Free Paper

(1) Call for Abstracts

Call for abstracts for International Session in the JSPRS2021 annual meeting will open on November 18th (Wed.) until January 6th (Wed.), 2021.
All free paper submissions will be considered eligible for one presentation: either Oral Presentation in International Session or Poster Presentation, in JSPRS2021

• Abstract submission site opens on November 18th (Wed.), 2020.
• Abstract submission deadline is January 6th (Wed.), 2021.
  Abstract submission deadline has been extended until January 20th (Wed.), 2021.
  Abstract submission is now closed. Thank you for your submission.
• All abstract submissions must be made in Word format.
• Abstracts Should be submitted via e-mail to jsprs64-abstracts@sunpla-mcv.com

(2) Responsibilities of the Presenting Author

• All authors submitting an abstract must register for the Annual Meeting by January 21st (Thu.), 2021.
  Those who have submitted an abstract will receive an e-mail from the Congress Secretariat in or after mid-December and will be asked to begin online registration for the Annual Meeting.
• The first author listed for each abstract serves as the presenting author and as the primary contact for all correspondence regarding the abstract.
• The presenting author must be one of the co-authors listed on the submitted abstract.
• The presenting author is responsible for ensuring that all authors have read the abstract and agreed to be co-authors.

(3) Presentation Format Decision (Oral presentation or Poster presentation)

After receiving submissions, the Review Committee of JSPRS2021 will decide whether the paper should be presented in Oral Presentation or Poster Presentation. Please note that these options cannot be changed after the review committee has reached its decision.

(4) About Presentation Method

We would like to ask the speakers of the International Session in the JSPRS2021 to give oral presentations at the venue in principle. However, depending on the state of the spread of the COVID-19 coronavirus, we plan to ask chairpersons and speakers to speak remotely online using Zoom webinar or other means. Poster Presentations will be posted as digital posters on the website. Therefore, we are waiting for a large number of submissions for the call for abstracts.

(5) Presentation Duration

Oral Presentation

Each speaker will have 10 minutes for presentation. Please time your talk for 8 minutes, and 2 minutes for questions.

Poster Presentation

Abstracts accepted for Poster Presentations will be posted as digital posters on the website.

(6) Abstract Review and Selection Process

• After the submission deadline, all completed and eligible abstracts will be made available to the Organizing Review Committees for blinded review and scoring, and final decisions will be made in late January 2021.
• Incomplete abstracts will not be reviewed.
• All abstracts submitted will be considered eligible for one presentation: either Oral Presentation or Poster Presentation.

(7) Acceptance/ Rejection Notification

• Notification regarding acceptance or rejection of abstracts will be sent to the presenting author by February 2021 by e-mail; consequently, an accurate e-mail address is critical. If your abstract is accepted, the e-mail will specify whether it is accepted as Oral Presentation or Poster Presentation. Rejection notifications will also be sent at that time.
• If you have not received an e-mail notification, please contact Congress Secretariat to the inquiry address shown at the bottom of this page.

(8) Conflict-Of-Interest (COI) Disclosure Policies

• Conflict-Of-Interest (COI) Policy requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict.
• Please disclose any relationships or circumstances that might affect or appear to affect the research presented. These relationships include you or any individual with whom you directly share income.
• AII authors and co-authors are required to provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author's view on the presentation; including relationships with pharmaceutical companies, or other companies whose products or services are related to the subject matter of the presentation topic. If no relevant relationships exist, this must be stated as well.

(9) Abstract Submission Instruction

• Abstracts must be made in Word format and be submitted via e-mail to jsprs64-abstracts@sunpla-mcv.com
• Once you have submitted your data, you will be able to return to edit and update it at any time until January 20th (Wed.), 2021.
• You cannot make any changes to your abstract after this date.
• All authors submitting an abstract must register for the Annual Meeting by January 21st (Thu.), 2021. Those who have submitted an abstract will receive an e-mail from the Congress Secretariat in or after mid-December and will be asked to begin online registration for the Annual Meeting.
• Your abstract file must include:
  • Your Name (Name of the First Author)
  • Name(s) of Affiliation (This will be printed in the Program Book)
  • Name(s) and Affiliation(s) for Co-Authors
  • Contact E-mail Address
  • Title of Abstract (within 15 words)
    The abstract title should be brief and clearly indicate the nature of the presentation. Do not put a period at the end of the title.
  • Abstract Body (within 250 words)
    The entire body of the abstract must not exceed 250 words.
    Spaces are not included in this number. No tables or diagrams should be included.
    Do not use bold type or underline formatting. Italic type is acceptable.
  • Keywords
    Please mention 2 or 3 keywords to your abstract. (Keywords will not be printed in the Program Book; they will be used as a reference for peer review.)

Abstract Form

• Please fill out the Abstract Form and submit it via e-mail to
  jsprs64-abstracts@sunpla-mcv.com.
  The subject of your e-mail should be:
  JSPRS2021 Abstract submission <Your name>

(10) Inquiries for Abstract Submission

Secretariat

Department of Plastic and Reconstructive Surgery,
Dokkyo Medical University School of Medicine
880 Kitakobayashi, Mibu, Shimotsugagun, Tochigi 321-0293, Japan

* For inquiries about abstract submissions, please contact the Congress Secretariat at the e-mail address below.

Congress Secretariat

Medical Convention Division, Sunplanet Co., Ltd.
6F Sumitomo Seisen Koishikawa Bldg.
3-5-10 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan
E-mail: jsprs64-inquiry@sunpla-mcv.com